Recruiting

MRgRTStereotactic MR-Adaptive Radiation Therapy for Early-stage Renal Cancer

Sponsor:

NYU Langone Health

Code:

NCT07767500

Conditions

Primary Renal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

MRI-guided linear accelerator

Magnetic resonance imaging (MRI)-guided radiation therapy (MRgRT)

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-26. This information was provided to ClinicalTrials.gov by NYU Langone Health on 2026-08-21.